PHARMEDOX LIMITED
Executive Summary
PHARMEDOX LIMITED operates in the high-innovation biotechnology R&D sector but remains dormant with negligible financial activity since incorporation. Its current status places it outside typical industry operational benchmarks, reflecting a pre-startup phase. Future competitive positioning will depend on its ability to engage actively in R&D and secure funding amidst a dynamic and capital-intensive market environment.
View Full Analysis Report →- Legal registered address
- 49 William Morris Close Oxford England OX4 2JX Copied!
Latest financial results as of 5 November 2025- Cash in bank
- £100
- Shareholders funds
- £100
View full financial accounts- Cash in bank
- £100
- Shareholders funds
- £100
- Company number
- 13644943 Copied!
Accounts
Latest annual accounts were to 30 September 2024
Next annual accounts are due by 30 June 2026
Company financial year end is on 30 September 2026
Confirmation statement
Latest confirmation statement statement dated 26 September 2025
Next statement due by 10 October 2026
Nature of business (SIC)
72110 - Research and experimental development on biotechnology
72190 - Other research and experimental development on natural sciences and engineering
Latest company documents
| Date | Description |
|---|---|
| 29/09/2529 September 2025 New | Confirmation statement made on 2025-09-26 with no updates |
| 02/06/252 June 2025 | Accounts for a dormant company made up to 2024-09-30 |
| 30/09/2430 September 2024 | Annual accounts for year ending 30 Sep 2024 |
| 26/09/2426 September 2024 | Confirmation statement made on 2024-09-26 with no updates |
| 07/10/237 October 2023 | Accounts for a dormant company made up to 2023-09-30 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company